Evidence map›Paper›PMID 39594746›Full record

ArticleCancers2024

A Hybrid Deep Learning and Machine Learning Approach with Mobile-EfficientNet and Grey Wolf Optimizer for Lung and Colon Cancer Histopathology Classification.

Raquel Ochoa-Ornelas, Alberto Gudiño-Ochoa, Julio Alberto García-Rodríguez

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Raquel Ochoa-OrnelasSystems and Computation Department, Tecnológico Nacional de México/Instituto Tecnológico de Ciudad Guzmán, Ciudad Guzmán 49100, Mexico.ORCID 0000-0003-1824-5789
Alberto Gudiño-OchoaElectronics Department, Tecnológico Nacional de México/Instituto Tecnológico de Ciudad Guzmán, Ciudad Guzmán 49100, Mexico.ORCID 0000-0002-2366-7452
Julio Alberto García-RodríguezCentro Universitario del Sur, Departamento de Ciencias Computacionales e Innovación Tecnológica, Universidad de Guadalajara, Ciudad Guzmán 49000, Mexico.ORCID 0000-0003-0339-0545

Funding

Tecnológico Nacional de México 20717.24-P
6 · The paper itself

Abstract

backgroundLung and colon cancers are among the most prevalent and lethal malignancies worldwide, underscoring the urgent need for advanced diagnostic methodologies. This study aims to develop a hybrid deep learning and machine learning framework for the classification of Colon Adenocarcinoma, Colon Benign Tissue, Lung Adenocarcinoma, Lung Benign Tissue, and Lung Squamous Cell Carcinoma from histopathological images.

methodsCurrent approaches primarily rely on the LC25000 dataset, which, due to image augmentation, lacks the generalizability required for real-time clinical applications. To address this, Contrast Limited Adaptive Histogram Equalization (CLAHE) was applied to enhance image quality, and 1000 new images from the National Cancer Institute GDC Data Portal were introduced into the Colon Adenocarcinoma, Lung Adenocarcinoma, and Lung Squamous Cell Carcinoma classes, replacing augmented images to increase dataset diversity. A hybrid feature extraction model combining MobileNetV2 and EfficientNetB3 was optimized using the Grey Wolf Optimizer (GWO), resulting in the Lung and Colon histopathological classification technique (MEGWO-LCCHC). Cross-validation and hyperparameter tuning with Optuna were performed on various machine learning models, including XGBoost, LightGBM, and CatBoost.

resultsThe MEGWO-LCCHC technique achieved high classification accuracy, with the lightweight DNN model reaching 94.8%, LightGBM at 93.9%, XGBoost at 93.5%, and CatBoost at 93.3% on the test set.

conclusionsThe findings suggest that our approach enhances classification performance and offers improved generalizability for real-world clinical applications. The proposed MEGWO-LCCHC framework shows promise as a robust tool in cancer diagnostics, advancing the application of AI in oncology.

Indexed as

artificial intelligencecolon cancerdeep learningEfficientNethistopathological imageslung cancermachine learningMobileNet

Identifiers

PMID39594746
PMCPMC11593226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.